Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Cri du Chat syndrome, also known as 5p- syndrome, was first identified by French geneticist Jérôme Lejeune in 1963. The condition is characterized by a distinctive high-pitched cry in infancy caused by a deletion on the short arm of chromosome 5, a discovery that fundamentally changed the landscape of clinical cytogenetics. When and how was Cri du Chat syndrome first identified? The medical history of Cri du Chat syndrome began in 1963 when the renowned French geneticist Jérôme Lejeune published his observations of three children who exhibited a characteristic "cat-like" cry, intellectual disability, and microcephaly.
TL;DR: Cri du Chat syndrome, also known as 5p- syndrome, was first identified by French geneticist Jérôme Lejeune in 1963. The condition is characterized by a distinctive high-pitched cry in infancy caused by a deletion on the short arm of chromosome 5, a discovery that fundamentally changed the landscape of clinical cytogenetics.
The medical history of Cri du Chat syndrome began in 1963 when the renowned French geneticist Jérôme Lejeune published his observations of three children who exhibited a characteristic "cat-like" cry, intellectual disability, and microcephaly. Lejeune, who previously discovered the chromosomal basis of Down syndrome, identified that these children shared a common genetic anomaly: the deletion of the short arm of chromosome 5. This discovery marked Cri du Chat syndrome as one of the first human conditions to be linked directly to a specific chromosomal deletion, providing a foundational case study for the emerging field of clinical cytogenetics.
In the decades following its discovery, the clinical definition of Cri du Chat syndrome expanded significantly. While early literature focused almost exclusively on the signature cry and severe physical impairments, modern research has mapped the "critical region" on chromosome 5 (specifically 5p15.3) responsible for the vocalization phenotype. We now understand that the severity of Cri du Chat syndrome varies widely based on the size and location of the deletion. Advanced molecular techniques, such as Fluorescence In Situ Hybridization (FISH) and chromosomal microarray analysis (CMA), have replaced older, less sensitive staining methods, allowing clinicians to detect even subtle deletions that were previously missed.
The history of Cri du Chat syndrome is defined by a transition from purely observational medicine to targeted genetic care. Key milestones include:
Historically, Cri du Chat syndrome was often misunderstood, with children frequently institutionalized in the mid-20th century due to a lack of understanding regarding their potential for development. The rise of patient advocacy groups in the late 20th century shifted the narrative from "clinical observation" to "holistic support." Today, the 104 members of the DiseaseMaps.org community demonstrate that individuals with Cri du Chat syndrome can achieve significant developmental milestones through structured support, early therapy, and community-based education, debunking outdated misconceptions about the limitations of the condition.
Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.